- Presentations
- 3
- Markets
- 2
Signifor is a brand of Pasireotide marketed by Recordati Rare Diseases, with 3 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Pasireotide
- Brand owner
- Recordati Rare Diseases
- Registered in
- European Union, United States
- Strengths and forms
- 0.3 mg/1 mL injection, 0.6 mg/1 mL injection, 0.9 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Signifor 0.3 mg/1 mL injectionSubcutaneous | Recordati Rare Diseases | US FDA | Available on request |
| Signifor 0.6 mg/1 mL injectionSubcutaneous | Recordati Rare Diseases | US FDA | Available on request |
| Signifor 0.9 mg/1 mL injectionSubcutaneous | Recordati Rare Diseases | US FDA | Available on request |
Equivalent brands
Other brands of Pasireotide.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Signifor
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.